Male C57BL/6 mice (8 wk of age) purchased from Hunan Slack King Experimental Animal company (Changsha, China) were injected intraperitoneally with a single dose of 30 mg/kg body weight cisplatin. Control mice were injected with a comparable volume of saline. To study the effects of FGF21, recombinant FGF21 was dissolved in PBS and administered intraperitoneally at 0.1 μg/g body weight 1 h before cisplatin injection followed by injection every 8 h. A comparable volume of PBS was given to the no-FGF21 animals. Mice were euthanized at d 3. All animal experiments were performed according to a protocol approved by the Institutional Committee for the Care and Use of Laboratory Animals of Second Xiangya Hospital at Central South University.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.